Stocktoria
908 Devices Inc. MASS
908 Devices Inc. (MASS) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the grey zone. It does not currently pay a dividend. FY2025 revenue was $56.2M at a 34.7% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -1.2 — elevated (above the −1.78 line — aggressive-accounting signals worth a closer look) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.581 |
| Retained earnings / assets | -1.175 |
| EBIT / assets | -0.207 |
| Equity / liabilities | 3.099 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| MASS | 908 Devices Inc. | 3/9 | 1.84 | 17 | +17.7% |
| BCHT | Birchtech Corp. | 4/9 | — | — | +1.3% |
| AATC | AUTOSCOPE TECHNOLOGIES CORP | 5/9 | 11.38 | 12.8 | +0.5% |
| OWLT | Owlet, Inc. | 4/9 | -9.08 | — | +35.4% |
| QSI | Quantum-Si Inc | 1/9 | 0.75 | — | — |
| UCLE | US NUCLEAR CORP. | 5/9 | — | — | — |
| GEOS | GEOSPACE TECHNOLOGIES CORP | 1/9 | 8.01 | — | -18.3% |
About 908 Devices Inc.
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
FAQ
Is MASS financially healthy?
908 Devices Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does MASS pay a dividend?
No, 908 Devices Inc. does not currently pay a dividend.
How profitable is MASS?
In FY2025, 908 Devices Inc. had a net margin of 34.7% and a return on equity of 13.6%.
What is MASS's P/E ratio?
908 Devices Inc.'s trailing price-to-earnings (P/E) ratio is about 17.0×, based on its latest annual earnings.
What is the analyst price target for MASS?
The average Wall-Street price target for 908 Devices Inc. is $11.00, about 9.8% above the recent price, from 2 analysts.
Is MASS a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on 908 Devices Inc.: a Piotroski F-score of 3/9, an Altman Z″ in the grey zone, a P/E of about 17.0×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.